 |
市場調查報告書
商品編碼
1749306
NPS+(美國) - 乾癬性關節炎NPS+ (US) - Psoriatic Arthritis |
||||||
美國風濕病醫師在治療乾癬性關節炎方面有很多選擇。然而，有些藥物的忠誠度和滿意度明顯高於其他藥物。這是為什麼呢？影響醫師選擇的關鍵因素有哪些？各領導品牌與競爭對手相比如何？本報告將帶您深入了解美國領先的乾癬性關節炎藥物。
主要的問題:
- 1.不同品牌的淨推薦值 (NPS) 如何比較？
- 2.醫師對特定品牌的忠誠度如何？
- 3.哪些品牌訊息能引起醫師的共鳴？
- 4.影響醫師藥物選擇的關鍵因素有哪些？
- 5.領先品牌的市佔率是多少？
- 6.各主要品牌相對於其競爭對手的定位為何？
- 7.哪些品牌因為品牌滿意度低而面臨較高的轉換風險？
領導品牌:
|
|
|
調查手法:
FirstView 報告是基於對透過 LiMATM 選出的醫生進行的定量調查。 LiMATM 是全球最大的醫生資料庫，擁有超過 300 萬名註冊醫生。所有醫生均根據嚴格的篩選標準精心挑選，以確保收集到的見解具有相關性、可靠性，並準確反映第一線醫務人員的真實意見和經驗。調查結果以直觀易懂的圖表形式呈現，方便快速理解和分析。憑藉 LiMA 廣泛的覆蓋率和精準度，FirstView 報告提供無與倫比的數據驅動洞察，協助在瞬息萬變的醫療保健市場中做出策略決策。
本報告特性：
FirstWord Reports 是值得信賴的行業領導者，專注於製藥業，為生物製藥專業人士和決策者提供深入可行的洞察。我們深厚的行業知識提供相關且有價值的信息，以識別新興趨勢並有效應對複雜課題。我們的報告以廣泛的研究以及來自領先專家和關鍵意見領袖 (KOL) 的獨立中立分析為後盾，確保了高度的準確性和可靠性。我們的報告還提供全面的市場趨勢視角，包括獨家訪談和數據，以及持續的市場監測。 FirstWord Reports 涵蓋醫生洞察（KOL 觀點和定量調查結果）以及醫療事務、數位健康、銷售和行銷以及 40 多個疾病領域的市場准入等領域的行業專家觀點。
There are various options available to US rheumatologists treating psoriatic arthritis. Clearly, some of these options achieve greater levels of loyalty and satisfaction than others, but why? What are the key factors driving physician choice, and how does each of the leading brands compare to its competitors? Gain insights into leading psoriatic arthritis therapies in the US.
Key Questions Answered:
- 1. How do NPS scores by brand compare?
- 2. How loyal are physicians to specific brands?
- 3. What brand messages resonate with physicians?
- 4. What are the key factors driving physician choice?
- 5. What is the market share of leading brands?
- 6. How does each of the leading brands compare to its competitors?
- 7. Which brands are vulnerable to switching due to low brand satisfaction?
Key Brands:
|
|
|
Methodology:
FirstView reports are developed from quantitative surveys conducted with physicians selected through LiMATM, the world's largest physician directory, containing over 3 million vetted and verified physicians. Each physician is carefully chosen based on strict screening criteria to ensure the insights gathered are both relevant and reliable, reflecting the true sentiments and experiences of leading medical professionals. The findings are presented in a series of easy-to-interpret charts, enabling you to quickly grasp and analyze the data. By leveraging the vast reach and precision of LiMATM, FirstView Reports provide unparalleled, data-driven insights to guide your strategic planning and help you stay ahead in a fast-evolving healthcare landscape.
What makes our reports different?
FirstWord Reports, a trusted industry leader with an exclusive focus on the pharmaceutical sector, delivers in-depth, actionable insights for biopharma professionals and decision-makers. Our deep industry knowledge enables us to provide relevant and valuable insights that help you identify emerging trends and navigate complex challenges effectively. Backed by extensive research and independent, impartial insights from leading experts and KOLs, our reports deliver the accuracy and reliability you need. With exclusive access to interviews and data unavailable elsewhere, along with ongoing market monitoring, we give you a comprehensive view of market dynamics. Covering over 40 dynamic disease areas and providing physician intelligence, including KOL insights and quantitative physician surveys, as well as industry expert views on issues in medical affairs, digital health, sales & marketing, market access, and other areas, our reports empower you to make smarter, data-driven decisions and maintain a competitive edge in a fast-moving industry.
